Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Gyre Therapeutics Inc. (NASDAQ : GYRE ) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. It mainly focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options. The company emphasizes product development efforts in the field of hemostasis and to develop valuable therapies for individuals with hemophilia. It is engaged in the clinical development of improved, next-generation subcutaneous prophylaxis using enhanced potency Factor VIIa and Factor IX variants.
Quote
| Last: | $7.96 |
|---|---|
| Change Percent: | 1.14% |
| Open: | $7.88 |
| Close: | $7.87 |
| High: | $7.99 |
| Low: | $7.85 |
| Volume: | 22,679 |
| Last Trade Date Time: | 04/15/2026 12:40:51 pm |
Stock Data
| Market Cap: | $767,775,261 |
|---|---|
| Float: | 71,190,203 |
| Insiders Ownership: | 0.16% |
| Institutions: | 17 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | www.gyretx.com |
| Country: | US |
| City: | San Diego |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Gyre Therapeutics Inc. (NASDAQ: GYRE).
